Feasibility of Azacitidine and Venetoclax Followed by High/Intermediate Dose Cytarabine (HIDAC/IDAC) Consolidation in Previously Untreated Acute Myeloid Leukemia Patients Unfit for Intensive Chemotherapy in a Resource Constraint Low-Middle Income Country: A Pilot Study
Clinical Lymphoma Myeloma and Leukemia（2024）
关键词
Acute Myeloid Leukemia,Azacytidine -Venetoclax,AML,HIDAC/IDAC consolidation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要